Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Biol. Res ; 44(3): 229-234, 2011. ilus, tab
Article in English | LILACS | ID: lil-608618

ABSTRACT

Testis-mediated gene transfer (TMGT) has been used as in vivo gene transfer technology to introduce foreign DNA directly into testes, allowing mass gene transfer to offspring via mating. In this study, we used plasmid DNA (pEGFP-N1) mixed with dimethylsulfoxide (DMSO), N,N-dimethylacetamide (DMA) or liposome (Lipofectin) in an attempt to improve TMGT. Males receiving consecutive DNA complex injections were mated to normal females to obtain F0 progeny. In vivo evaluation of EGFP expression, RT-PCR and PCR were used to detect the expression and the presence of exogenous DNA in the progeny. We also evaluated possible testicular damage by histological procedures. PC R and RT-PCR analyses revealed that liposome and DMSO increased the rate of TMGT. Histological analyses demonstrated that repeated (4 times) injections of DNA complexes can affect spermatogenesis. DMSO was the most deleterious among the reagents tested. In this study, we detected the presence of transgene in the progeny, and its expression in blood cells. Consecutive injections of DNA complexes were associated with impaired spermatogenesis, suggesting requirement of optimal conditions for DNA delivery through TMGT.


Subject(s)
Animals , Female , Mice , Dimethyl Sulfoxide/pharmacology , Gene Transfer Techniques , Green Fluorescent Proteins/administration & dosage , Mice, Transgenic/genetics , Testis , Transgenes , Animals, Genetically Modified , Genetic Vectors/administration & dosage , Genetic Vectors/genetics , Green Fluorescent Proteins/analysis , Green Fluorescent Proteins/genetics , Liposomes/pharmacology , Mice, Inbred BALB C , Polymerase Chain Reaction , Testis/drug effects , Testis/pathology , Transfection/methods
2.
Experimental & Molecular Medicine ; : 161-167, 2011.
Article in English | WPRIM | ID: wpr-34111

ABSTRACT

The development of clinically applicable scaffolds is important for the application of cell transplantation in various human diseases. The aims of this study are to evaluate fibrin glue in a novel protein replacement therapy using proliferative adipocytes and to develop a mouse model system to monitor the delivery of the transgene product into the blood and the fate of the transduced cells after transplantation. Proliferative adipocytes from mouse adipose tissue were transduced by a retroviral vector harboring the human lecithin-cholesterol acyltransferase (lcat) gene, and were subcutaneously transplanted into mice combined with fibrin glue. The lcat gene transduction efficiency and the subsequent secretion of the product in mouse adipocytes were enhanced using a protamine concentration of 500 microg/ml. Adipogenesis induction did not significantly affect the lcat gene-transduced cell survival after transplantation. Immunohistochemistry showed the ectopic enzyme production to persist for 28 days in the subcutaneously transplanted gene-transduced adipocytes. The increased viability of transplanted cells with fibrin glue was accompanied with the decrease in apoptotic cell death. The immunodetectable serum LCAT levels in mice implanted with the fibrin glue were comparable with those observed in mice implanted with Matrigel, indicating that the transplanted lcat gene-transduced adipocytes survived and functioned in the transplanted spaces with fibrin glue as well as with Matrigel for 28 days. Thus, this in vivo system using fibrin is expected to serve as a good model to further improve the transplanted cell/scaffold conditions for the stable and durable cell-based replacement of defective proteins in patients with LCAT deficiency.


Subject(s)
Animals , Humans , Male , Mice , Adipocytes/cytology , Blotting, Western , Cell Differentiation , Cell Survival/drug effects , Cells, Cultured , Collagen/metabolism , Drug Combinations , Drug Delivery Systems , Fibrin Tissue Adhesive/administration & dosage , Genetic Vectors/administration & dosage , Laminin/metabolism , Mice, Inbred C57BL , Mice, Nude , Phosphatidylcholine-Sterol O-Acyltransferase/genetics , Proteoglycans/metabolism , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Tissue Engineering
3.
Experimental & Molecular Medicine ; : 638-645, 2011.
Article in English | WPRIM | ID: wpr-155752

ABSTRACT

The E2F-1 transcription factor is post-translationally modified and stabilized in response to various forms of DNA damage to regulate the expression of cell-cycle and pro-apoptotic genes. The sustained overexpression of E2F-1 is a characteristic feature of gastric cancer. In this study, we investigated the role of short hairpin RNA (shRNA) targeting E2F-1 gene on human gastric cancer MGC-803 cell growth in vivo, and preliminarily revealed the mechanism. Thus, we constructed recombinant pGCSIL-GFP-shRNA-E2F-1 lentiviral vector to knock down E2F-1 expression in human gastric cancer MGC-803 cells in vivo, and studied the effect of E2F-1 shRNA on growth of MGC-803 tumor and evaluated its treatment efficacy. Our data demonstrated that in a mouse model of established gastric cancer, intratumor injection of lentiviral shRNA targeting E2F-1 definitely decreased the endogenous E2F-1 mRNA and protein expression in MGC-803 tumor, and inhibited tumor growth and promoted tumor cells apoptosis. Moreover, we found that E2F-1 shRNA increased the expression of phosphatase and tensin homolog (PTEN), activated caspase-3 and caspase-9, and suppressed nuclear factor (NF)-kappaB expression in tumor tissue as determined by reverse transcription (RT)-PCR and western blotting. In summary, shRNA targeting of E2F-1 can effectively inhibits human gastric cancer MGC-803 cell growth in vivo and may be a potential therapeutic strategy for gastric cancer.


Subject(s)
Animals , Humans , Male , Mice , Apoptosis , Blotting, Western , Caspase 3/metabolism , Caspase 9/metabolism , Cells, Cultured , E2F1 Transcription Factor/antagonists & inhibitors , Genetic Vectors/administration & dosage , Lentivirus/genetics , Mice, Inbred BALB C , Mice, Nude , RNA Interference , RNA, Small Interfering/genetics , Stomach Neoplasms/genetics
4.
Arq. bras. oftalmol ; 73(5): 447-453, Sept.-Oct. 2010. graf
Article in English | LILACS | ID: lil-570508

ABSTRACT

PURPOSE: To evaluate the transfer of heterologous genes carrying a Green Fluorescent Protein (GFP) reporter cassette to primary corneal epithelial cells ex vivo. METHODS: Freshly enucleated rabbit corneoscleral tissue was used to obtain corneal epithelial cell suspension via enzymatic digestion. Cells were plated at a density of 5×10³ cells/cm² and allowed to grow for 5 days (to 70-80 percent confluency) prior to transduction. Gene transfer was monitored using fluorescence microscopy and fluorescence activated cell sorter (FACS). We evaluated the transduction efficiency (TE) over time and the dose-response effect of different lentiviral particles. One set of cells were dual sorted by fluorescence activated cell sorter for green fluorescent protein expression as well as Hoechst dye exclusion to evaluate the transduction of potentially corneal epithelial stem cells (side-population phenotypic cells). RESULTS: Green fluorescent protein expressing lentiviral vectors were able to effectively transduce rabbit primary epithelial cells cultured ex vivo. Live cell imaging post-transduction demonstrated GFP-positive cells with normal epithelial cell morphology and growth. The transduction efficiency over time was higher at the 5th post-transduction day (14.1 percent) and tended to stabilize after the 8th day. The number of transduced cells was dose-dependent, and at the highest lentivirus concentrations approached 7 percent. When double sorted by fluorescence activated cell sorter to isolate both green fluorescent protein positive and side population cells, transduced side population cells were identified. CONCLUSIONS: Lentiviral vectors can effectively transfer heterologous genes to primary corneal epithelial cells expanded ex vivo. Genes were stably expressed over time, transferred in a dose-dependence fashion, and could be transferred to mature corneal cells as well as presumable putative stem cells.


OBJETIVO: Avaliar a transferência de genes heterólogos expressando a proteí­na "Green Fluorescent Protein" (GFP) para células corneanas epiteliais primárias ex vivo utilizando vetor lentivírus. MÉTODOS: Tecido corneoescleral de coelhos foi usado para obtenção de suspensão de células corneanas epitelias. As células foram semeadas na densidade de 5×10³ células/cm² e expandidas por 5 dias até uma confluência de 70-80 por cento antes de serem transduzidas. A transferência genética foi monitorada por microscopia fluorescente e por um separador de células ativadas por fluorescência. Foram avaliadas a eficiência de transdução ao longo do tempo e o efeito dose-resposta de diferentes quantidades de partículas virais. Um grupo de células foi analisado pelo separador de células ativadas por fluorescência para avaliar a transdução de células com fenótipo de cé­lulas tronco do epitélio corneano (baseado na exclusão do corante "Hoechst dye"). RESULTADOS: Os vetores lentivírus foram efetivos na transdução de cé­lulas corneanas epiteliais primárias de coelhos ex vivo. Fotodocumentação das células vivas demonstrou células epiteliais de morfologia normal e expressando o gene fluorescente (GFP). A eficiência de transdução ao longo do tempo foi maior no quinto dia após a transdução (14,1 por cento) e demonstrou uma tendência à estabilidade a partir do oitavo dia após a transdução. O número de células transduzidas foi dose-dependente e atingiu 7 por cento com as maiores concentrações de partículas virais. Quando analisadas pelo separador de células ativadas por fluorescência para detecção de células transduzidas e também de células que excluíram o corante "Hoechst dye", foi detectado que células com fenótipo de células tronco do epitélio corneano ("side-population") também foram transduzidas. CONCLUSÕES: Os vetores lentivirais podem transferir genes heterolólogos para células corneanas epiteliais primárias expandidas ex vivo de forma eficiente. Os genes foram expressos de forma estável ao longo do tempo e puderam ser transferidos tanto para células epiteliais maduras como para presumíveis células tronco epiteliais. A eficiência de transdução foi obtida de forma dose-dependente.


Subject(s)
Animals , Rabbits , Epithelium, Corneal/metabolism , Genetic Vectors/administration & dosage , Green Fluorescent Proteins/genetics , Lentivirus/genetics , Transduction, Genetic/methods , Analysis of Variance , Epithelium, Corneal/cytology , Genetic Therapy/methods , Green Fluorescent Proteins/administration & dosage , Models, Animal
5.
Experimental & Molecular Medicine ; : 684-695, 2010.
Article in English | WPRIM | ID: wpr-193635

ABSTRACT

The study investigated the effects of adenovirus-mediated gene transfection of basic fibroblast growth factor (bFGF), bFGF combined with interleukin-1 receptor antagonist protein (IL-Ra) and/or insulin-like growth factor-1 (IGF-1) both in human osteoarthritis (OA) chondrocytes and rabbits OA model. Human OA chondrocytes were delivered by adenovirus-mediated bFGF, IL-Ra and IGF-1 vectors, respectively. Chondrocyte proliferation, glycosaminoglycan (GAG) content, expression of type II collagen, ADAMTS-5, MMP-13, MMP-3 and TIMP-1 were determined. Rabbit OA model was induced by anterior cruciate ligament transaction (ACLT) in knees. Adenoviral vectors encoding human bFGF, IL-Ra and IGF-1 were injected intraarticularly into the knee joints after ACLT. The effects of adenovirus- mediated gene transfection on rabbit OA were evaluated. In vitro, the transfected genes were expressed in cell supernatant of human OA chondrocytes. AdbFGF group significantly promoted chondrocyte proliferation, and increased GAG and type II collagen synthesis than in the OA group. As two or three genes were transfected in different combinations, there was significant enhancement on the GAG content, type II collagen synthesis, and TIMP-1 levels, while ADAMTS-5, MMP-13, and MMP-3 levels were reduced. In vivo, the transfected genes were expressed in synovial fluid of rabbits. Intraarticular delivery of bFGF enhanced the expression of type II collagen in cartilage and decreased cartilage Mankin score compared with the OA control group (P = 0.047; P < 0.01, respectively). Multiple-gene transfection in different combinations showed better results than bFGF transfection alone. This study suggests that bFGF gene transfection is effective in treating experimental OA. Multiple gene transfection has better biologic effects on OA.


Subject(s)
Animals , Humans , Rabbits , Adenoviridae/genetics , Chondrocytes/drug effects , Collagen Type II/genetics , Fibroblast Growth Factor 2/genetics , Genetic Therapy/methods , Genetic Vectors/administration & dosage , Insulin-Like Growth Factor I/genetics , Interleukin 1 Receptor Antagonist Protein/genetics , Interleukin-1/genetics , Matrix Metalloproteinase 13/genetics , Matrix Metalloproteinase 3/genetics , Osteoarthritis/therapy , Tissue Inhibitor of Metalloproteinase-1/genetics , Transfection
6.
Journal of Korean Medical Science ; : 108-111, 2003.
Article in English | WPRIM | ID: wpr-63344

ABSTRACT

The delivery of transgenes to the central nervous system (CNS) can be a valuable tool to treat CNS diseases. Various systems for the delivery to the CNS have been developed; vascular delivery of viral vectors being most recent. Here, we investigated gene transfer to the CNS by intravenous injection of recombinant adenoviral vectors, containing green fluorescence protein (GFP) as a reporter gene. Expression of GFP was first observed 6 days after the gene transfer, peaked at 14 days, and almost diminished after 28 days. The observed expression of GFP in the CNS was highly localized to hippocampal CA regions of cerebral neocortex, inferior colliculus of midbrain, and granular cell and Purkinje cell layers of cerebellum. It is concluded that intravenous delivery of adenoviral vectors can be used for gene delivery to the CNS, and hence the technique could be beneficial to gene therapy.


Subject(s)
Animals , Female , Mice , Adenoviruses, Human/isolation & purification , Blood-Brain Barrier , Brain/virology , Cerebellum/cytology , Cerebellum/virology , Comparative Study , Genes, Reporter , Genetic Vectors/administration & dosage , Genetic Vectors/isolation & purification , Genetic Vectors/pharmacokinetics , Hippocampus/virology , Inferior Colliculi/virology , Injections, Intravenous , Luminescent Proteins/analysis , Luminescent Proteins/biosynthesis , Luminescent Proteins/genetics , Mice, Inbred BALB C , Neuroglia/virology , Neurons/virology , Purkinje Cells/virology , Pyramidal Cells/virology , Recombinant Fusion Proteins/analysis , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Tail/blood supply , Tissue Distribution
7.
Experimental & Molecular Medicine ; : 299-307, 2002.
Article in English | WPRIM | ID: wpr-134589

ABSTRACT

Enhanced extracellular matrix (ECM) accumulation is an important finding in human restenotic arterial neointima after angioplasty. Transforming growth factor b1(TGF-beta1) is known to regulate the synthesis and turnover of a variety of ECM components, and may play an important role in restenosis. Recombinant adenoviral vector expressing an ectodomain of the TGF-beta type II receptor fused to the human immunoglobulin Fc portion (AdT beta-ExR) inhibits the action of TGF-beta probably either by adsorbing TGF-beta or by acting as a dominant negative receptor. We carried out a catheter-based local adenovirus mediated gene delivery using an Infiltrator in porcine coronary arteries to know the pattern of gene expression, efficacy and procedural complications. Twenty four coronary arteries in 13 pigs were used for intravascular gene delivery by intramural injection with either AdT beta-ExR or adenovirus expressing b-galactosidase (AdCALacZ). Direct immunofluorescent staining and reverse transcription polymerase chain reaction (RTPCR) were used for detection of type II TGF-beta receptor and its mRNA respectively. X-Gal histochemistry was performed to identify b-galactosidase. Both soluble TGF-beta receptor and b-galactosidase were expressed locally in the media and adventita at injected arterial segments without any significant dissemination to remote area. Intravascular gene transfection performed with various titer of each adenoviral vector showed that AdT beta-ExR of 5x10(8) pfu and AdCALacZ of 2.5 x 10(8) pfu were the minimum titer for the expression of each transgene. Infiltration of CD3 positive T cells was detected by immunohistochemical staining in the area of each transgene expression, and tends to decrease over time after gene delivery. Pathological study of 24 treated arteries showed complications such as disruption of external elastic lamina with hemorrhage (n = 4), minimal disruption of internal elastic lamina and endothelial layer, and medial thickening. In conclusion, catheter-based local intravascular gene delivery of adenoviral vector is feasible and effective in a selected artery, but must be undertaken with caution due to possible lethal complications. Local delivery of soluble TGF-beta type II receptor in this way may provide an effective intravascular gene therapy to inhibit TGF-beta signal pathway without any significant systemic side effect.


Subject(s)
Animals , Female , Adenoviridae/genetics , Catheters, Indwelling , Coronary Vessels/metabolism , Gene Expression , Genetic Therapy/adverse effects , Gene Transfer Techniques , Genetic Vectors/administration & dosage , Inflammation/etiology , Receptors, Transforming Growth Factor beta/analysis , Swine , Transgenes , beta-Galactosidase/genetics
8.
Experimental & Molecular Medicine ; : 299-307, 2002.
Article in English | WPRIM | ID: wpr-134588

ABSTRACT

Enhanced extracellular matrix (ECM) accumulation is an important finding in human restenotic arterial neointima after angioplasty. Transforming growth factor b1(TGF-beta1) is known to regulate the synthesis and turnover of a variety of ECM components, and may play an important role in restenosis. Recombinant adenoviral vector expressing an ectodomain of the TGF-beta type II receptor fused to the human immunoglobulin Fc portion (AdT beta-ExR) inhibits the action of TGF-beta probably either by adsorbing TGF-beta or by acting as a dominant negative receptor. We carried out a catheter-based local adenovirus mediated gene delivery using an Infiltrator in porcine coronary arteries to know the pattern of gene expression, efficacy and procedural complications. Twenty four coronary arteries in 13 pigs were used for intravascular gene delivery by intramural injection with either AdT beta-ExR or adenovirus expressing b-galactosidase (AdCALacZ). Direct immunofluorescent staining and reverse transcription polymerase chain reaction (RTPCR) were used for detection of type II TGF-beta receptor and its mRNA respectively. X-Gal histochemistry was performed to identify b-galactosidase. Both soluble TGF-beta receptor and b-galactosidase were expressed locally in the media and adventita at injected arterial segments without any significant dissemination to remote area. Intravascular gene transfection performed with various titer of each adenoviral vector showed that AdT beta-ExR of 5x10(8) pfu and AdCALacZ of 2.5 x 10(8) pfu were the minimum titer for the expression of each transgene. Infiltration of CD3 positive T cells was detected by immunohistochemical staining in the area of each transgene expression, and tends to decrease over time after gene delivery. Pathological study of 24 treated arteries showed complications such as disruption of external elastic lamina with hemorrhage (n = 4), minimal disruption of internal elastic lamina and endothelial layer, and medial thickening. In conclusion, catheter-based local intravascular gene delivery of adenoviral vector is feasible and effective in a selected artery, but must be undertaken with caution due to possible lethal complications. Local delivery of soluble TGF-beta type II receptor in this way may provide an effective intravascular gene therapy to inhibit TGF-beta signal pathway without any significant systemic side effect.


Subject(s)
Animals , Female , Adenoviridae/genetics , Catheters, Indwelling , Coronary Vessels/metabolism , Gene Expression , Genetic Therapy/adverse effects , Gene Transfer Techniques , Genetic Vectors/administration & dosage , Inflammation/etiology , Receptors, Transforming Growth Factor beta/analysis , Swine , Transgenes , beta-Galactosidase/genetics
9.
São Paulo; s.n; 2001. 146 p. ilus, tab, graf.
Thesis in Portuguese | LILACS | ID: lil-313770

ABSTRACT

No lúmen do intestino médio da larva de Tenebrio molitor existem 4 "beta"-glicosidases (denominadas 1, 2, 3a e 3b), que não estão presentes na comida do animal. Elas foram purificadas usando-se técnicas de eletroforese e cromatografias de troca iônica e interação hidrofóbica. A "beta"-glicosidase 1 (Mr 59.000) é instável a 30ºC mas é estabilizada na presença do substrato. Ela praticamente não tem atividade sobre galactosídeos e cliva di- e oligossacarídeos. A enzima possui apenas 1 sítio ativo que apresenta 4 subsítios para ligação de glicose. Seu papel fisiológico deve ser o da clivagem de oligo- e principalmente dissacarídeos. A "beta"-glicosidase 2 (Mr 67.000) é muito instável a 30ºC e hidrolisar...


Subject(s)
Animals , Enzyme Activation/physiology , Enzymes , Glycoside Hydrolases , In Vitro Techniques , Intestines , Tenebrio , Genetic Vectors/administration & dosage , Sequence Analysis, DNA/methods , Sequence Analysis, DNA , Blotting, Western , Cloning, Molecular , Chromatography, Ion Exchange , Electrophoresis
10.
Rev. Inst. Med. Trop. Säo Paulo ; 40(5): 291-4, Sept.-Oct. 1998. tab
Article in English | LILACS | ID: lil-225849

ABSTRACT

Foram produzidos quatro lotes de antigeno rabico a partir de suspensoes de virus resultantes de celulas BHK21 infectadas, aderidas a microcarregadores do tipo Cytodex 1 e cultivadas em biorreator. Em paralelo foi utilizada a metodologia de producao de virus rabico com celulas BHK21 em monocamadas, contidas em garrafas de 350cm2. Os resultados encontrados demonstraram que os titulos infectantes foram de 10 elevado a 6.69 DL50/mL para as suspensoes virais obtidas em garrafas e 10 elevado a 7.28 DL50/mL para as do biorreator. Os volumes das suspensoes virais colhidas foram, em media de 11.900 mL por lote do biorreator e 800 mL por garrafa. Com o antigeno produzido no biorreator foram imunizados 10 cavalos. As medias dos titulos de anticorpos anti-rabicos encontrados nos soros destes animais foram de 240 e 212 UI/mL, respectivamente apos a base e o primeiro reforco. Atraves da infeccao de celulas BHK21 aderidas, a microcarregadores e cultivadas em biorreator, pode-se obter antigeno rabico em larga escala e com titulos infectantes satisfatorios


Subject(s)
Animals , Cell Adhesion/immunology , Antigen-Presenting Cells/immunology , Rabies Vaccines/immunology , Antigen-Presenting Cells/virology , Bioreactors/virology , Cells, Cultured , Horses/virology , Receptors, Antigen, B-Cell , Genetic Vectors/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL